U.S. markets open in 27 minutes

Galectin Therapeutics, Inc. (GALT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.7100+0.0700 (+2.65%)
At close: 4:00PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Premium required to access quarterly data
Quarterly
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
0
0
Operating Expense
17,737
13,438
13,602
16,247
21,481
Operating Income
-17,737
-13,438
-13,602
-16,247
-21,481
Net Non Operating Interest Income Expense
146
144
-298
12
45
Pretax Income
-17,591
-13,294
-13,900
-16,235
-21,436
Net Income Common Stockholders
-17,751
-20,179
-15,047
-17,467
-22,350
Diluted NI Available to Com Stockholders
-17,751
-20,179
-15,047
-17,467
-22,350
Basic EPS
-
0
0
0
0
Diluted EPS
-
0
0
0
0
Basic Average Shares
-
52,238
39,414
35,521
29,216
Diluted Average Shares
-
52,238
39,414
35,521
29,216
Total Operating Income as Reported
-17,737
-13,438
-13,602
-16,247
-21,481
Total Expenses
17,737
13,438
13,602
16,247
21,481
Net Income from Continuing & Discontinued Operation
-17,591
-13,294
-13,900
-16,235
-21,436
Normalized Income
-17,591
-13,294
-13,900
-16,235
-21,436
Interest Income
233
231
38
24
45
Interest Expense
87
87
336
12
-
Net Interest Income
146
144
-298
12
45
EBIT
-17,504
-13,207
-13,564
-16,223
-21,481
EBITDA
-17,470
-
-
-
-
Reconciled Depreciation
34
35
0
1
7
Net Income from Continuing Operation Net Minority Interest
-17,591
-13,294
-13,900
-16,235
-21,436
Normalized EBITDA
-17,470
-13,172
-13,564
-16,222
-21,474
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0